Advanced Cellular Therapeutics
We aim to develop novel immunotherapies to treat childhood cancer. We will utilise cutting edge genetic and genome engineering tools to modify patients’ own immune system. The modified immune cells which are then empowered to recognise the cancer, will be provided as ‘living drug’ cell therapies.
![A/Prof Geoffrey McCowage](/sites/default/files/2023-11/pdrgeoffmccowage.jpg)
title
A/Prof Geoffrey McCowage
![Dr Kavitha Gowrishankar](/sites/default/files/2023-11/Kavitha%20Gowrishankar.jpg)
title
Dr Kavitha Gowrishankar
![Dr Caroline Bateman](/sites/default/files/2023-11/pdrcarolinebateman.jpg)
title
Dr Caroline Bateman
More team members
- Dr Amanda Tan - Postdoctoral fellow, Principal scientist, CAR T cell clinical manufacture
- Ms Sayali Gore - PhD student
- Dr Robyn Walsh - Clinical Trials Project manager/ Coordinator